These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 393516

  • 1. Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumour antigen.
    Thomson DM, Tataryn DN, Schwartz R, MacFarlane JK.
    Eur J Cancer (1965); 1979 Sep; 15(9):1095-106. PubMed ID: 393516
    [No Abstract] [Full Text] [Related]

  • 2. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO, Tataryn DN, MacFarlane JK, Thomson DM, Schwartz R.
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [Abstract] [Full Text] [Related]

  • 3. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE.
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract] [Full Text] [Related]

  • 4. Leukocyte adherence inhibition assay in human pulmonary neoplasia.
    Kotlar HK, Eker P, Brennhovd I, Høst H, Høie J, Sanner T.
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):141-6. PubMed ID: 7047165
    [Abstract] [Full Text] [Related]

  • 5. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
    Tsang PH, Roboz JP, Holland JF, Bekesi JG.
    Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D, Kaufmann M, Drings P, Fedra G.
    Oncology; 1978 Jan; 35(6):242-5. PubMed ID: 370704
    [Abstract] [Full Text] [Related]

  • 7. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ, Koppi TA, Khan JM, Davis NC.
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [Abstract] [Full Text] [Related]

  • 8. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK, Sanner T.
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [Abstract] [Full Text] [Related]

  • 9. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM, Grosser N.
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract] [Full Text] [Related]

  • 10. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
    Maluish A, Halliday WJ.
    J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
    [No Abstract] [Full Text] [Related]

  • 11. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
    MacFarlane JK, Thomson DM, Phelan K, Shenouda G, Scanzano R.
    Cancer; 1982 Mar 15; 49(6):1185-93. PubMed ID: 7037158
    [Abstract] [Full Text] [Related]

  • 12. Human cancers transplanted in nude mice retain the expression of their organ-specific neoantigens.
    Thomson DM, Neville AM, Phelan K, Scanzano RS, Vandevoorde JP.
    Eur J Cancer Clin Oncol; 1981 Nov 15; 17(11):1191-7. PubMed ID: 7199466
    [No Abstract] [Full Text] [Related]

  • 13. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients.
    Kotlar HK, Sanner T.
    Cancer Lett; 1980 Nov 15; 11(1):11-9. PubMed ID: 7013972
    [Abstract] [Full Text] [Related]

  • 14. The use of cryopreserved lymphocytes in the leukocyte adherence inhibition assay. I. Evaluation of specificity of responses in cancer patients.
    Waldman SR, Yonemoto RH.
    Int J Cancer; 1978 May 15; 21(5):542-51. PubMed ID: 350778
    [No Abstract] [Full Text] [Related]

  • 15. Leukocyte adherence inhibition assay in immunodiagnosis of colon cancers.
    Cavallini G, Berti G, Tioli P.
    Ital J Surg Sci; 1984 May 15; 14(4):281-8. PubMed ID: 6398321
    [Abstract] [Full Text] [Related]

  • 16. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
    Goldrosen MH, Howell JH, Holyoke ED.
    Cancer Res; 1979 Feb 15; 39(2 Pt 2):630-2. PubMed ID: 367588
    [Abstract] [Full Text] [Related]

  • 17. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM.
    Cancer Res; 1979 Feb 15; 39(2 Pt 2):627-9. PubMed ID: 83917
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of leukocyte migration by a human colon cancer extract.
    Sirianni MC, Luzi G, Iavarone C, Papaluca M, Fiorilli M, Messinetti S, Aiuti F.
    Tumori; 1981 Feb 15; 67(3):163-7. PubMed ID: 7025399
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
    Howell JH, Russo AJ, Goldrosen MH.
    Cancer Res; 1979 Feb 15; 39(2 Pt 2):612-8. PubMed ID: 83914
    [No Abstract] [Full Text] [Related]

  • 20. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M, Marti JH, Grosser N, MacFarlane JK, Thomson DM.
    Cancer; 1977 Feb 15; 39(2):494-505. PubMed ID: 319891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.